Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune-Related Adverse Events”

262 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 262 results

Not applicableStudy completedNCT02377284
What this trial is testing

Prevention and Management of Food Allergies

Who this might be right for
EmpathyFood Allergy
University of Pennsylvania 187
Not applicableNot Yet RecruitingNCT03969693
What this trial is testing

Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation

Who this might be right for
Mediastinal LymphomaHodgkin LymphomaNon Hodgkin Lymphoma
Chang Gung Memorial Hospital 50
Not applicableUnknownNCT03640884
What this trial is testing

Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study

Who this might be right for
Adverse Drug EventAdverse Drug ReactionsAnaphylactic Reaction+1 more
Zhong Wang 30,000
Not applicableLooking for participantsNCT07131007
What this trial is testing

Construction and Evaluation of Tumor Immunotherapy and Organ Damage Early Warning System Based on Multi-omics

Who this might be right for
Malignant NeoplasmOrgan Damage
Hebei Medical University Fourth Hospital 2,000
Not applicableUnknownNCT03147157
What this trial is testing

The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation

Who this might be right for
Liver TransplantationGraft Versus Host DiseaseGraft Rejection+1 more
The First Hospital of Jilin University 120
Testing effectiveness (Phase 2)Ended earlyNCT00074165
What this trial is testing

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Who this might be right for
Brain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/OrganLymphoma+1 more
OHSU Knight Cancer Institute 17
Testing effectiveness (Phase 2)Study completedNCT00333736
What this trial is testing

Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration

Who this might be right for
Human Immunodeficiency Virus
Canadian Immunodeficiency Research Collaborative 337
Not applicableUnknownNCT03917537
What this trial is testing

WGA in Platinum-refractory HNSCC Underwent Nivolumab

Who this might be right for
HNSCC
Chang Gung Memorial Hospital 80
Not applicableUnknownNCT04791150
What this trial is testing

Rheumatologic Adverse Events and Cancer Immunotherapy

Who this might be right for
OncologyAutoimmunityArthritis+1 more
Poitiers University Hospital 400
Testing effectiveness (Phase 2)Looking for participantsNCT06406114
What this trial is testing

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

Who this might be right for
Drug AllergyCephalosporin AllergyDrug Hypersensitivity+4 more
Massachusetts General Hospital 300
Not applicableLooking for participantsNCT07167251
What this trial is testing

Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids

Who this might be right for
Immune Related Adverse EventsImmune-Mediated HepatitisCancer
University Hospital, Basel, Switzerland 63
Testing effectiveness (Phase 2)Study completedNCT01597375
What this trial is testing

Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)

Who this might be right for
Asthma, Aspirin-InducedAspirin Exacerbated Asthma
Elliot Israel, MD 46
Not applicableStudy completedNCT06247865
What this trial is testing

BIO-CHECKPOINT 0 Biomarkers to Identify Oncology Patients on ICPI at Greater Risk of irAE

Who this might be right for
Neoplasms
Portsmouth Hospitals NHS Trust 120
Not applicableLooking for participantsNCT06613165
What this trial is testing

Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer

Who this might be right for
Immune-related Adverse EventNeoadjuvant TherapydMMR Colorectal Cancer
Xijing Hospital 100
Not applicableUnknownNCT01122303
What this trial is testing

Corneal Epitheliotropic Factors in Autologous Serum Eye Drops in Nonautoimmune and Stevens-Johnson Syndrome With Dry Eye

Who this might be right for
Stevens-Johnson Syndrome
Mahidol University 20
Not applicableUnknownNCT01952275
What this trial is testing

Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases

Who this might be right for
Other Specified Inflammatory Disorders of Skin or Subcutaneous TissuePyoderma GangrenosumErosive Pustular Dermatosis of the Scalp+25 more
University of Zurich 600
Not applicableLooking for participantsNCT05840575
What this trial is testing

Investigating Cognitive Impairment in Young Patients With Cancer Prospectively

Who this might be right for
Chemotherapy-Related Cognitive ImpairmentChemotherapeutic ToxicityChemo-brain+7 more
Rigshospitalet, Denmark 100
Not applicableNot Yet RecruitingNCT07008027
What this trial is testing

Real World Asparaginase Therapy Toxicity

Who this might be right for
Drug Toxicity
St. Jude Children's Research Hospital 200
Not applicableEnded earlyNCT01320072
What this trial is testing

Diagnosis of Aspirin Hypersensitivity in Aspirin Exacerbated Respiratory Disease

Who this might be right for
Asthma, Aspirin-induced
Montefiore Medical Center 29
Not applicableUnknownNCT05969379
What this trial is testing

Investigational Biomarkers for Neurological Immune-related Adverse Events

Who this might be right for
Neurological Disease
Hospices Civils de Lyon 80
Load More Results